EBOS Group (EBO) Stock Price, News & Analysis

Company Overview

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, New Zealand, and Southeast Asia. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. In addition, the company supplies health and wellness products to public and private hospitals, day surgeries, general practice, aged care facilities, specialist clinics, government, and non-profit health agencies, as well as clinically essential products; and provides pharmacy services to private and public hospitals, cancer centers, correctional facilities, and veterinary clinics. Further, it offers allografts solutions; healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; and surgical devices and medical consumables. Additionally, the company provides pet nutrition, treats, clean-up, and grooming products and accessories; and wholesales veterinary products for companion animals, production animals, and equine athletes. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 4,371 shs
• Average Volume: N/A
• Market Capitalization: A$8.20 billion
• P/E Ratio: 27.51
• Dividend Yield: 2.31%
• Price Target: N/A
• Consensus Rating: N/A

EBO Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of EBOS Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that EBOS Group investors own include Take-Two Interactive Software (TTWO), Snowflake (SNOW), Shopify (SHOP), Meridian Energy (MEZ), ikeGPS Group (IKE), Infratil (IFT) and HEXO (HEXO).

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Medical Distribution
• Sub-Industry: N/A
• Current Symbol: ASX:EBO
• CIK: N/A
• Web: www.ebosgroup.com
• Phone: 61 3 9918 5555
• Fax: N/A
• Employees: 5,000
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): A$1.40
• Trailing P/E Ratio: 27.51
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: A$271.55 million
• Net Margins: 2.06%
• Pretax Margin: N/A
• Return on Equity: 11.26%
• Return on Assets: 4.58%

Debt

• Debt-to-Equity Ratio: 66.89
• Current Ratio: 0.95
• Quick Ratio: 0.76

Sales & Book Value

• Annual Sales: A$13.19 billion
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 12.24
• Book Value: A$13.72 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 194,670,000
• Free Float: N/A
• Market Cap: A$8.20 billion
• Optionable: Not Optionable
• Beta: 0.26